期刊文献+

儿童非霍奇金淋巴瘤肾脏浸润的临床观察 被引量:2

Renal invasion caused by non-Hodgkin's lymphomas in children
下载PDF
导出
摘要 目的 了解儿童非霍奇金淋巴瘤 (NHL)肾脏浸润的临床特征。方法  1998年 10月至 1999年 10月该院血液 /肿瘤科收治的 19名初治NHL患儿 ,治疗前进行形态分类、免疫分型、影像学检查、相关的血生化检查、可能相关的病原学等调查 ,临床分期后给予相应的治疗及随访。结果  6例 (31.6 % )确诊时即有肾脏浸润 ,均为Ⅲ~Ⅳ期NHL患儿 ,血LDH值均升高≥ 2倍正常值 ;1例血EB病毒VCA IgA 1∶10阳性。 5例患儿接受了治疗 ,3例获完全缓解 (CR) ,其肾脏浸润均于 1疗程化疗后消失 ,B超和CT显示肾脏形态恢复正常。结论 晚期NHL患儿诊断时有肾脏浸润者不少见 ,多见于高肿瘤负荷者 ;腹部B超和CT检查能及时发现肾脏受累及程度 ;采用B或TNHLCCCG 97Ⅲ~Ⅳ期方案治疗有效 ;EB病毒与该组NHL的发病无明显相关性。
出处 《中国当代儿科杂志》 CAS CSCD 2003年第4期345-347,共3页 Chinese Journal of Contemporary Pediatrics
  • 相关文献

参考文献5

  • 1汤静燕,王耀平,梁辉,赵惠君,薛惠良.免疫分型指导治疗小儿晚期非霍奇金淋巴瘤[J].中华血液学杂志,1999,20(5):272-273. 被引量:7
  • 2汤静燕,潘慈,徐敏,许谨,薛惠良,陈静,陈静,赵惠君,顾龙君,王耀平.儿童神经母细胞瘤多学科协作分组分治临床报告[J].中国实用儿科杂志,2002,17(2):80-82. 被引量:14
  • 3王耀平 见:佘亚雄 应大明.非霍奇金淋巴瘤[A].见:佘亚雄,应大明.小儿肿瘤学[C].上海:上海科学技术出版社,1997.159—167.
  • 4Aziza S, IT Magrath. Malignent non- Hodgkin's lymphomas in children. In: Philip AP, David GP, editer. Principles and practice of pediatric oncology [M]. 3rd ped. Philadelphia: Lippincott- Raven Publishers, 1997, 545 - 587.
  • 5Grenzebach J, Schrappe M, Ludwig WD, et al. Favorable outcome for children and adolescents with T - cell lymphoblastic lymphoma with an intensive ALL- type therapy without local radiotherapy [J]. Ann Hematol, 2001, 80 (Suppl 3): B73-6.

二级参考文献6

  • 1汤静燕 王耀平 等.小儿恶性淋巴瘤56例治疗体会[J].中华儿科杂志,1997,35:103-103.
  • 2Stram DO, Matthay KK, O'Leary M, et al. Consolidation chemo-radiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma: a report of two concurrent children's cancer group studies. J Clin Oncol, 1996,14(16):2417
  • 3George RE, Variend S,Cullinane C, et al. Relationship between histopathological features, MYCN amplification, and prognosis: A UKCCSG study. Med Pediatri Oncol, 2001,36(1):169
  • 4Matthay KK, Villablanca JG, Seeger RC, et al. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. The New England J Med, 1999,341(16):1165
  • 5汤静燕,中华儿科杂志,1997年,35卷,103页
  • 6汤静燕,王耀平,金惠明,赵慧君,薛惠良,梁辉,应大明.晚期神经母细胞瘤35例治疗及长期随访[J].中华儿科杂志,1997,35(7):385-386. 被引量:5

共引文献19

同被引文献27

  • 1Reiter A, Klapper W. Recent advances in the understanding and management of diffuse large B-cell lymphoma in children[J]. Br J Haematol, 2008, 142(3): 329-347.
  • 2Oschlies I, Klapper W, Zimmermann M, et al. Diffuse large B-cell lymphoma in pediatric patients belongs predominantly to the germinal-center type B-cell lymogomas: a clinicopathologic analysis of cases included in the German BFM(Berlin-Frankfurt- Munster) Multicenter Trial [J]. Blood, 2006, 107(10): 4047-4052.
  • 3Murphy SB. Classification, staging and end results of treatment of childhood non-Hodgkin's lymphomas: dissimilarities from lymphomas in adults[J]. Semin Oncol, 1980, 7(3): 332-339.
  • 4Pillon M, Di TuUio MT, Garaventa A, et al. Long-term results of the first Italian Association of Pediatric Hematology and Oncology protocol for the treatment of pediatric B-cell non-Hodgkin lymphoma (AIEOP LNH92)[J]. Cancer, 2004, 101(2): 385-394.
  • 5Patte C, Auperin A, Gerrard M, et al. Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non- Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients[J]. Blood, 2007, 109(7): 2773-2780.
  • 6Gerrard M, Cairo MS, Weston C, et al. Excellent survival following two courses of COPAD chemotherapy in children and adolescents with resected localized B-cell non-Hodgkin's lymphoma: results of the FAB/LMB96 international study[J]. Br J Haematol, 2008, 141(6): 840-847.
  • 7Cairo MA, Gerrard M, Sposto R, et al. Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents[J]. Blood, 2007, 109(7): 2736-2743.
  • 8NCI. CTCAE[EB/OL]. [May 17, 2010]. http://evs.nci.nih.gov/ftpl/ CTCAE/About. html.
  • 9Cairo MS, Sposto R, Gerrard M, et al. Advanced stage, increased lactate dehydrogenase, and primary site, but not adolescent age( ≥ 15 years), are associated with an increased risk of treatment failure in children and adolescents with mature B-cell non-Hodgkin's lymphoma: results of the FAB LMB 96 study[J]. J Clin Oncol, 2012, 30(4): 387-393.
  • 10Lones MA, Raphael M, Perkins SL, et al. Mature B-cell lymphoma in children and adoescents: International group pathologist consensus correlates with histology technical quality[J]. J Pediatr Hematol Oncol, 2006, 28(9): 568-574.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部